Mice have been made resistant to HIV by sabotaging a gene in the blood cells that the virus normally infects. Researchers who developed the treatment at Sangamo BioSciences, a biotechnology company in Duarte, California, US, hope to test it in patients by the end of 2008. If successful, the treatment could offer a more effective way for controlling HIV in patients with the disease, the researchers